Literature DB >> 26172508

MicroRNA-375 Suppresses Extracellular Matrix Degradation and Invadopodial Activity in Head and Neck Squamous Cell Carcinoma.

Lizandra Jimenez, Ved P Sharma, John Condeelis, Thomas Harris, Thomas J Ow, Michael B Prystowsky, Geoffrey Childs, Jeffrey E Segall1.   

Abstract

CONTEXT: Head and neck squamous cell carcinoma (HNSCC) is a highly invasive cancer with an association with locoregional recurrence and lymph node metastasis. We have previously reported that low microRNA-375 (miR-375) expression levels correlate with poor patient survival, increased locoregional recurrence, and distant metastasis. Increasing miR-375 expression in HNSCC cell lines to levels found in normal cells results in suppressed invasive properties. HNSCC invasion is mediated in part by invadopodia-associated degradation of the extracellular matrix.
OBJECTIVE: To determine whether elevated miR-375 expression in HNSCC cell lines also affects invadopodia formation and activity.
DESIGN: For evaluation of the matrix degradation properties of the HNSCC lines, an invadopodial matrix degradation assay was used. The total protein levels of invadopodia-associated proteins were measured by Western blot analyses. Immunoprecipitation experiments were conducted to evaluate the tyrosine phosphorylation state of cortactin. Human protease arrays were used for the detection of the secreted proteases. Quantitative real time-polymerase chain reaction measurements were used to evaluate the messenger RNA (mRNA) expression of the commonly regulated proteases.
RESULTS: Increased miR-375 expression in HNSCC cells suppresses extracellular matrix degradation and reduces the number of mature invadopodia. Higher miR-375 expression does not reduce cellular levels of selected invadopodia-associated proteins, nor is tyrosine phosphorylation of cortactin altered. However, HNSCC cells with higher miR-375 expression had significant reductions in the mRNA expression levels and secreted levels of specific proteases.
CONCLUSIONS: MicroRNA-375 regulates invadopodia maturation and function potentially by suppressing the expression and secretion of proteases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26172508      PMCID: PMC4628565          DOI: 10.5858/arpa.2014-0471-OA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  100 in total

1.  Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer.

Authors:  Georgios Pampalakis; Georgia Sotiropoulou
Journal:  Biol Chem       Date:  2006-06       Impact factor: 3.915

2.  Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC).

Authors:  Nijiro Nohata; Toyoyuki Hanazawa; Naoko Kikkawa; Muradil Mutallip; Daiju Sakurai; Lisa Fujimura; Kazumori Kawakami; Takeshi Chiyomaru; Hirofumi Yoshino; Hideki Enokida; Masayuki Nakagawa; Yoshitaka Okamoto; Naohiko Seki
Journal:  J Hum Genet       Date:  2011-07-14       Impact factor: 3.172

3.  Recent advances in head and neck cancer.

Authors:  Robert I Haddad; Dong M Shin
Journal:  N Engl J Med       Date:  2008-09-11       Impact factor: 91.245

Review 4.  Degrading devices: invadosomes in proteolytic cell invasion.

Authors:  Stefan Linder; Christiane Wiesner; Mirko Himmel
Journal:  Annu Rev Cell Dev Biol       Date:  2011-07-21       Impact factor: 13.827

Review 5.  A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.

Authors:  Boudewijn J M Braakhuis; Maarten P Tabor; J Alain Kummer; C René Leemans; Ruud H Brakenhoff
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

6.  Nck1 and Grb2 localization patterns can distinguish invadopodia from podosomes.

Authors:  Matthew Oser; Athanassios Dovas; Dianne Cox; John Condeelis
Journal:  Eur J Cell Biol       Date:  2010-09-17       Impact factor: 4.492

7.  ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis.

Authors:  Xin Lu; Qiongqing Wang; Guohong Hu; Catherine Van Poznak; Martin Fleisher; Michael Reiss; Joan Massagué; Yibin Kang
Journal:  Genes Dev       Date:  2009-07-16       Impact factor: 11.361

8.  Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells.

Authors:  H Sato; M Seiki
Journal:  Oncogene       Date:  1993-02       Impact factor: 9.867

9.  Cortactin regulates cofilin and N-WASp activities to control the stages of invadopodium assembly and maturation.

Authors:  Matthew Oser; Hideki Yamaguchi; Christopher C Mader; J J Bravo-Cordero; Marianela Arias; Xiaoming Chen; Vera Desmarais; Jacco van Rheenen; Anthony J Koleske; John Condeelis
Journal:  J Cell Biol       Date:  2009-08-24       Impact factor: 10.539

10.  The microRNA.org resource: targets and expression.

Authors:  Doron Betel; Manda Wilson; Aaron Gabow; Debora S Marks; Chris Sander
Journal:  Nucleic Acids Res       Date:  2007-12-23       Impact factor: 16.971

View more
  11 in total

1.  Apolipoprotein E Promotes Invasion in Oral Squamous Cell Carcinoma.

Authors:  Sangeeta K Jayakar; Olivier Loudig; Margaret Brandwein-Gensler; Ryung S Kim; Thomas J Ow; Berrin Ustun; Thomas M Harris; Michael B Prystowsky; Geoffrey Childs; Jeffrey E Segall; Thomas J Belbin
Journal:  Am J Pathol       Date:  2017-07-24       Impact factor: 4.307

2.  MicroRNA-375 targets PAX6 and inhibits the viability, migration and invasion of human breast cancer MCF-7 cells.

Authors:  Qiongyan Zou; Wenjun Yi; Jianghai Huang; Fenfen Fu; Gannong Chen; Dewu Zhong
Journal:  Exp Ther Med       Date:  2017-06-13       Impact factor: 2.447

3.  miR-375 Regulates Invasion-Related Proteins Vimentin and L-Plastin.

Authors:  Lizandra Jimenez; Jihyeon Lim; Berta Burd; Thomas M Harris; Thomas J Ow; Nicole Kawachi; Thomas J Belbin; Ruth Angeletti; Michael B Prystowsky; Geoffrey Childs; Jeffrey E Segall
Journal:  Am J Pathol       Date:  2017-05-10       Impact factor: 4.307

4.  Effect of selective small molecule inhibitors on MMP-9 and VEGFR-1 expression in p16-positive and -negative squamous cell carcinoma.

Authors:  Benedikt Kramer; Johannes David Schultz; Clemens Hock; Alexander Sauter; Boris A Stuck; Karl Hörmann; Richard Birk; Christoph Aderhold
Journal:  Oncol Lett       Date:  2017-03-13       Impact factor: 2.967

5.  Reactivation of super-enhancers by KLF4 in human Head and Neck Squamous Cell Carcinoma.

Authors:  Maria Tsompana; Christian Gluck; Isha Sethi; Ishita Joshi; Jonathan Bard; Norma J Nowak; Satrajit Sinha; Michael J Buck
Journal:  Oncogene       Date:  2019-09-02       Impact factor: 9.867

6.  Expression of human papillomavirus oncoproteins E6 and E7 inhibits invadopodia activity but promotes cell migration in HPV-positive head and neck squamous cell carcinoma cells.

Authors:  Charissa N Kahue; Rachel J Jerrell; Aron Parekh
Journal:  Cancer Rep (Hoboken)       Date:  2018-07-27

7.  Diagnostic and Prognostic Value of MicroRNAs in Metastasis and Recurrence of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Ke Qiu; Yao Song; Yufang Rao; Qiurui Liu; Danni Cheng; Wendu Pang; Jianjun Ren; Yu Zhao
Journal:  Front Oncol       Date:  2021-09-27       Impact factor: 6.244

8.  Rac3 regulates breast cancer invasion and metastasis by controlling adhesion and matrix degradation.

Authors:  Sara K Donnelly; Ramon Cabrera; Serena P H Mao; John R Christin; Bin Wu; Wenjun Guo; Jose Javier Bravo-Cordero; John S Condeelis; Jeffrey E Segall; Louis Hodgson
Journal:  J Cell Biol       Date:  2017-10-23       Impact factor: 10.539

9.  Targeting invadopodia-mediated breast cancer metastasis by using ABL kinase inhibitors.

Authors:  Tomer Meirson; Alessandro Genna; Nikola Lukic; Tetiana Makhnii; Joel Alter; Ved P Sharma; Yarong Wang; Abraham O Samson; John S Condeelis; Hava Gil-Henn
Journal:  Oncotarget       Date:  2018-04-24

10.  Direct measurement of vertical forces shows correlation between mechanical activity and proteolytic ability of invadopodia.

Authors:  E Dalaka; N M Kronenberg; P Liehm; J E Segall; M B Prystowsky; M C Gather
Journal:  Sci Adv       Date:  2020-03-11       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.